Alzamend Neuro Inc (ALZN) vs Xenetic Biosciences, Inc. (XBIO)
A side-by-side comparison of Alzamend Neuro Inc and Xenetic Biosciences, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
ALZN
Alzamend Neuro Inc
$1.37HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
XBIO
Xenetic Biosciences, Inc.
$2.12HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
Total return — ALZN vs XBIO
growth of $100 · dividends reinvested · last 5yALZN -100.0% (-84.9%/yr)XBIO -90.0% (-36.9%/yr)XBIO compounded faster over this window
Log scale — wide-divergence pair
ALZN XBIO
ALZN vs XBIO: by the numbers
- •ALZN is the larger company ($5M vs $5M market cap).
- •Both run net losses; ALZN's is the smaller (0.00% vs -75.90% net margin).
Metrics side by side
Valuation
| Metric | ALZN | XBIO |
|---|---|---|
| P/S ratio | N/A | 1.49 |
| P/B ratio | 0.90 | 0.80 |
Profitability
| Metric | ALZN | XBIO |
|---|---|---|
| Gross margin | 0.00% | 100.00% |
| Operating margin | 0.00% | -95.23% |
| Net margin | 0.00% | -75.90% |
| ROE | -156.77% | -40.76% |
| ROIC | -156.69% | -43.50% |
Growth (annualized)
| Metric | ALZN | XBIO |
|---|---|---|
| Revenue CAGR (5Y) | N/A | 34.31% |
| Total return CAGR (5Y) | -79.14% | -34.54% |
Frequently asked
- How have ALZN and XBIO total returns compared?
- Over the past 5 years, ALZN delivered -79.14% and XBIO delivered -34.54% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Alzamend Neuro ROEXenetic Biosciences ROEAlzamend Neuro operating marginXenetic Biosciences operating marginAlzamend Neuro revenue growthXenetic Biosciences revenue growthAlzamend Neuro free cash flowXenetic Biosciences free cash flow
Alzamend Neuro & Xenetic Biosciences appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.